arrhythmogenic in the old space of cardiomyopathy
Conditions
Brief summary
the degree of fibrosis of the left ventricular muscle in the CMR examination, left ventricular ejection fraction (LVEF) in CMR, ventricular arrhythmias load
Detailed description
NT-proBNP concentration and two fibrosis markers: sST2 and Gal-3, morphological and functional criteria (ECHO and CMR): the size of the left and right ventricles as well as generalized and focal contractility disorders, ECG: terminal activation delay (TAD) and extent of negative T waves in precordial leads, arrhythmias in the ECG, 24-hour Holter ECG recording, ergospirometry and ICD readings, physical capacity (pVO2) assessed on the basis of ergospirometric tests, hospitalization for symptoms of heart failure, sudden cardiac death
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the degree of fibrosis of the left ventricular muscle in the CMR examination, left ventricular ejection fraction (LVEF) in CMR, ventricular arrhythmias load | — |
Secondary
| Measure | Time frame |
|---|---|
| NT-proBNP concentration and two fibrosis markers: sST2 and Gal-3, morphological and functional criteria (ECHO and CMR): the size of the left and right ventricles as well as generalized and focal contractility disorders, ECG: terminal activation delay (TAD) and extent of negative T waves in precordial leads, arrhythmias in the ECG, 24-hour Holter ECG recording, ergospirometry and ICD readings, physical capacity (pVO2) assessed on the basis of ergospirometric tests, hospitalization for symptoms of heart failure, sudden cardiac death | — |
Countries
Poland